Pfenex Expects To Be Alone With Teriparatide

Not Expecting Teva Entry Until Later Next Year

 
• By Aidan Fry
  
Puzzle_Optimism
Pfenex believes it could get a significant head start with its rival to Lilly's Forteo teriparatide brand in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin